Cargando…
Multiple Sclerosis in Children: Differential Diagnosis, Prognosis, and Disease-Modifying Treatment
Pediatric-onset multiple sclerosis (POMS) is a rare neuroinflammatory and neurodegenerative disease that has a significant impact on long-term physical and cognitive patient outcomes. A small percentage of multiple sclerosis (MS) diagnoses occur before the age of 18 years. Before treatment initiatio...
Autores principales: | Jakimovski, Dejan, Awan, Samreen, Eckert, Svetlana P., Farooq, Osman, Weinstock-Guttman, Bianca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8697541/ https://www.ncbi.nlm.nih.gov/pubmed/34940954 http://dx.doi.org/10.1007/s40263-021-00887-w |
Ejemplares similares
-
Dimethyl Fumarate in the Treatment of Relapsing-Remitting Multiple Sclerosis: Patient Reported Outcomes and Perspectives
por: Ozel, Osman, et al.
Publicado: (2019) -
COVID-19 Vaccination in Multiple Sclerosis and Inflammatory Diseases: Effects from Disease-Modifying Therapy, Long-Term Seroprevalence and Breakthrough Infections
por: Jakimovski, Dejan, et al.
Publicado: (2022) -
Asymptomatic infection after BNT162b2 mRNA COVID-19 vaccination in multiple sclerosis patient
por: Jakimovski, Dejan, et al.
Publicado: (2021) -
A prospective study to validate the expanded timed get-up-and-go in a population with multiple sclerosis
por: Jakimovski, Dejan, et al.
Publicado: (2022) -
Infections, Vaccines and Autoimmunity: A Multiple Sclerosis Perspective
por: Jakimovski, Dejan, et al.
Publicado: (2020)